genetics

December 20, 2018 · Richard L. Schilsky, MD, FACP, FSCT, FASCO
Some recent FDA approvals have made many people aware of tumor-agnostic treatments. But what does that mean and how could it benefit someone with cancer? ASCO Chief Medical Officer Richard L. Schilsky gives insight into this new way of thinking about cancer treatment. Read More >>
November 6, 2018 · Tiffani DeMarco, MS, LCGC
Concerned about a family history of cancer? Learn how genetic counseling and testing can help you understand and manage your own cancer risk. Read More >>
Nora Lynn Henry, MD
October 9, 2018 · Norah Lynn Henry, MD
Did you know that breast cancer is the most common cancer in U.S. women, except for skin cancer? Lineagotica Associate Editor Dr. Norah Lynn Henry shares 9 important facts about the disease. Read More >>
2018 ASCO Annual Meeting; #ASCO18
June 2, 2018 · Greg Guthrie, ASCO staff
Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights address the connection between microsatellite instability and Lynch syndrome, a blood test that may be used to find early lung cancer, a new targeted therapy for treating advanced breast cancer, an immunotherapy-chemotherapy combination that slows lung cancer growth, and evidence that personalized medicine helps people with cancer live longer. Read More >>
2018 ASCO Annual Meeting; #ASCO18
May 16, 2018 · Monika Sharda, ASCO staff
Read key research highlights that will be presented at the 2018 ASCO Annual Meeting, including monitoring symptoms with technology, screening and genomic testing for lung cancer, and new treatment regimens for breast cancer and T-cell leukemia and lymphoma. Read More >>

Pages